
Belgium’s UCB to incorporate Accenture’s AI tech into pharmacovigilance efforts
The Belgian drugmaker will use Accenture's INTIENT Pharmacovigilance to monitor the safety of its drugs, including those that are on the market and in clinical trials. Germany's Bayer inked a similar deal with Genpact last year.